LI
PFE icon

LVZ Inc’s Pfizer PFE Stock Holding History

LVZ Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,676
Closed -$680K – 158
2023
Q1 		$680K Buy
16,676
+700
+4% +$30.2K 0.1% 60
2022
Q4 		$819K Buy
15,976
+482
+3% +$23.1K 0.13% 49
2022
Q3 		$678K Buy
15,494
+4
+0% +$194 0.12% 45
2022
Q2 		$812K Buy
15,490
+1,598
+12% +$81.4K 0.14% 38
2022
Q1 		$719K Buy
13,892
+833
+6% +$43.2K 0.1% 48
2021
Q4 		$771K Buy
13,059
+735
+6% +$36.4K 0.1% 45
2021
Q3 		$530K Buy
12,324
+451
+4% +$20K 0.08% 52
2021
Q2 		$465K Buy
11,873
+670
+6% +$26.1K 0.07% 60
2021
Q1 		$406K Sell
11,203
-366
-3% -$13K 0.06% 63
2020
Q4 		$426K Buy
11,569
+2,928
+34% +$107K 0.07% 62
2020
Q3 		$301K Buy
+8,641
New +$303K 0.06% 65
2020
Q1 		– Sell
-5,848
Closed -$217K – 82
2019
Q4 		$217K Sell
5,848
-176
-3% -$6.27K 0.04% 83
2019
Q3 		$205K Buy
+6,024
New +$219K 0.04% 75

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LVZ Inc's PFE Position: Q2 2023 in Review

LVZ Inc sold out of Pfizer (PFE) in Q2 2023, closing a stake of 16,676 shares — an estimated $680K sold.

LVZ Inc first reported a position in PFE in Q3 2019 and held it in 13 quarters. The position peaked at $819K in Q4 2022. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • LVZ Inc reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
  • LVZ Inc sold 16,676 Pfizer shares in Q2 2023, an estimated $680K.
  • LVZ Inc first reported a position in Pfizer in Q3 2019 and held it in 13 quarters.
  • LVZ Inc's Pfizer position peaked at $819K in Q4 2022.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on LVZ Inc's 13F filing for Q2 2023, filed 18 Jul 2023.